Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT07192302
Active, not recruiting Phase 1

Partial Rotator Cuff Injury Combined With Stiff Shoulder

NCT07192302 · tracked via the Priya Life Science China tracker
Sponsor
Hebei Medical University Third Hospital
Phase
Phase 1
Started
2025-06-01
Last updated
2026-01-16

Condition(s) studied

Rotator Cuff Tears of the ShoulderShoulder Adhesive CapsulitisShoulder Arthroscopy

Investigational drug(s) / intervention(s)

ArthroscopyDrugs administration

Arthroscopy: Early Surgical Intervention in Patients with Partial Rotator Cuff Tears and Concomitant Shoulder Stiffness.

Drugs administration: Oral Medication for Conservative Management of Partial Rotator Cuff Tears with Concomitant Shoulder Stiffness.

Study summary

A Randomized Controlled Trial Comparing Early Surgical Intervention Versus a Structured Rehabilitation Program with Delayed Surgery if Needed for Partial-Thickness Rotator Cuff Tears with Concomitant Shoulder Stiffness: The SPIRIT Trial (Surgery for Partial Tears with Immobility Randomized Intervention Trial)

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age 18-80 years. 2. Symptomatic shoulder pain for \>2 weeks. 3. MRI-confirmed partial-thickness rotator cuff tear (\>50% tendon thickness or \>5mm in length). 4. Concomitant shoulder stiffness, defined as passive range of motion loss of ≥25% in at least two planes (forward flexion, abduction, external rotation, or internal rotation) compared to the contralateral side. 5. Failure of a brief (≥2 weeks) trial of conservative care (e.g., oral NSAIDs). Exclusion Criteria: 1. Age\< 18 or \>80 years. 2. Full-thickness rotator cuff tear. 3. Previous surgery on the affected shoulder. 4. Glenohumeral osteoarthritis (Grade ≥2 Samilson-Prieto). 5. Cervical radiculopathy as a primary cause of symptoms. 6. Systemic inflammatory arthritis. 7. Neurologic disorder affecting the shoulder. 8. Contraindications to surgery or general anesthesia. 9. Inability to comply with the rehabilitation protocol.

Primary outcome measure(s)

  • Shoulder Pain and Disability Index （SPADI） — 6 month before surgery and 6 months after surgery
    Shoulder Pain and Disability Index （SPADI） from 0-100. The lower the number, the better the functional outcomes of the patients.

Trial sites (1)

FacilityCityRegionStatus
Jialiang Guo Shijiazhuang Hebei

More Hebei Medical University Third Hospital trials in China

The Research About the ACS After Femoropopliteal Arterial Injuries Recruiting
The Research About Acute Compartment Syndrome Recruiting
Researches About Proximal Humerus Fractures Recruiting

Other trials for the same condition

Effect of Liposomal Bupivacaine and Bupivacaine Hydrochloride for Superior Trunk Block of the Interscalene Brachial Plexus on Postoperative Diaphragmatic Function and Analgesia Enrolling by invitation
Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07192302 on ClinicalTrials.gov ↗ ← All trials in China